In fact, the findings of the present study demonstrate that overexpression of IMPDH2 in osteosarcoma cells induces strong chemoresistance to cisplatin and methotrexate, two drugs frequently used for osteosarcoma therapy. This evidence concerns the gene IMPDH2 and osteosarcoma.